PUBLICATIONS

Murray et al. Validation of a Circulating Tumor-Derived DNA Blood Test for Detection of Methylated BCAT1 and IKZF1 DNA. JALM 2017, doi: 10.1373/jalm.2017.023135

Mitchell et al. Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer. Genes 2016, 7(12), 125; doi:10.3390/genes7120125

Young et al. A Cross-sectional Study Comparing a Blood Test for Methylated BCAT1 and IKZF1 Tumor-derived DNA with CEA for Detection of Recurrent Colorectal Cancer. Cancer Medicine. doi:10.1002/cam4.868

Pedersen et al. A Two-Gene Blood Test for Methylated DNA Sensitive for Colorectal Cancer. PLoS One 2015;10(4):e0125041.

Symonds et al. A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia. Clin Trans Gastro. 2016; 7, e137.

Pedersen et al. Evaluation of an Assay for Methylated BCAT1 and IKZF1 in Plasma for Detection of Colorectal Neoplasia. BMC CANCER 15(1):654. October 2015.

Mitchell et al. A Panel of Genes Methylated with High Frequency in Colorectal Cancer. BMC Cancer. 2014;14:54.

Pedersen et al. CAHM, a Long Non-Coding RNA Gene Hypermethylated in Colorectal Neoplasia.Epigenetics. 2014 Aug;9(8):1071-82.

LaPointe et al. Discovery and Validation of Molecular Biomarkers for Colorectal Adenomas and Cancer with Application to Blood Testing. PLoS One. 2012;7(1):e29059.

Graham et al. Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas. Genes Cancer. 2011 Aug;2(8):829-40.

LaPointe et al. Map of Differential Transcript Expression in the Normal Human Large Intestine. Physiol Genomics. 2008 Mar 14;33(1):50-64.